Turnstone BiologicsTSBX
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 28 institutions reported holding Turnstone Biologics Corp. (TSBX) in their 13F filings, up 4 from Q3 2024. 7 opened new positions and 3 sold out. The largest holders were Orbimed Advisors LLC ($1.5M), FMR LLC ($586K) and Point72 Asset Management ($464K). 4 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Turnstone Biologics Corp.
- CUSIP
- 90042W100
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $106K |
| Exits | 3 | $281K |
All 13F filers, Q3 2024 → Q4 2024: 238,315 shares bought and 584,868 shares sold, net −346,553 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Orbimed Advisors LLC | 0.03% | No change | 3,099,265 | $1.5M |
| FMR LLC | 0.00% | Add +0.9% | 1,184,043 | $586K |
| Point72 Asset Management | 0.00% | Add +0.2% | 934,364 | $464K |
| PFM Health Sciences, LP | 0.04% | No change | 932,348 | $463K |
| Takeda Pharmaceutical Co. Ltd. | 1.69% | No change | 895,824 | $448K |
| Bank of America Corp. | 0.00% | Reduce -2.2% | 891,526 | $442K |
| Citadel Advisors | 0.00% | No change | 689,213 | $342K |
| Vanguard Group Inc. | 0.00% | No change | 578,995 | $287K |
| 72 Investment Holdings, LLC | 0.56% | No change | 549,980 | $273K |
| Sectoral Asset Management Inc. | 0.17% | No change | 517,648 | $257K |
| FIL Ltd | 0.00% | No change | 192,657 | $95K |
| Geode Capital Management, LLC | 0.00% | Add +4.4% | 138,659 | $69K |
| Barclays PLC | 0.00% | Add +3.6% | 114,058 | $57K |
| Millennium Management | 0.00% | Reduce -28.4% | 73,744 | $37K |
| Susquehanna International Group, LLP | 0.00% | New | 67,324 | $33K |
| Citigroup Inc. | 0.00% | New | 61,413 | $30K |
| BlackRock, Inc. | 0.00% | Add +0.6% | 43,192 | $21K |
| Renaissance Technologies | 0.00% | New | 23,900 | $12K |
| Goldman Sachs Group Inc. | 0.00% | New | 20,518 | $10K |
| Northern Trust Corp. | 0.00% | No change | 18,405 | $9K |
| BNP Paribas Financial Markets | 0.00% | New | 15,238 | $8K |
| Virtu Financial LLC | 0.00% | New | 14,810 | $7K |
| Acadian Asset Management LLC | 0.00% | Reduce -51.1% | 17,833 | $7K |
| XTX Topco Ltd | 0.00% | New | 11,759 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -3.4% | 4,806 | $2K |
| Morgan Stanley | 0.00% | Reduce -21.7% | 4,701 | $2K |
| JPMorgan Chase & Co. | 0.00% | Add +25.9% | 199 | $98 |
| UBS Group AG | 0.00% | Reduce -99.3% | 71 | $35 |
"% of holder's portfolio" is TSBX's weight in each manager's 13F, not the share of Turnstone Biologics Corp. the manager owns.